Moreover, rapamycin (an PI3K inhibitor) and 3-methyladenine (3-MA) (an mTOR inhibitor), the most widely used autophagy inducer or inhibitor, were employed to investigate their ability to modify the autophagic flux in 5,6-ECs treated MM cells. The gene discussed is MTOR; the disease is Miyoshi myopathy.